MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.090
-0.020 (-1.80%)
Aug 5, 2026, 1:00 PM EDT - Market open
MaxCyte Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 32.29 | 33.03 | 38.63 | 41.29 | 44.26 | 33.89 |
Revenue Growth | -14.30% | -14.50% | -6.44% | -6.72% | 30.59% | 29.52% |
Gross Profit Gross Profit Growth | 25.99 | 26.8 | 31.53 | 36.55 | 39.16 | 30.25 |
Operating Income Operating Income Growth | -45.79 | -51.9 | -51.2 | -48.3 | -27.36 | -18.19 |
Net Income Net Income Growth | -39.12 | -44.63 | -41.06 | -37.92 | -23.57 | -19.08 |
Earnings Per Share EPS Growth | -0.37 | -0.42 | -0.39 | -0.37 | -0.23 | -0.21 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 19.66 | 21.08 | 25.77 | 32.42 | 44.26 | 33.89 |
Outside The United States Outside The United States Growth | 12.63 | 11.95 | 12.86 | 8.87 | - | - |
Total Total Growth | 32.29 | 33.03 | 38.63 | 41.29 | 44.26 | 33.89 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 106.85 | 103.04 | 154.48 | 168.29 | 227.34 | 255.04 |
Total Debt Total Debt Growth | 17.49 | 17.94 | 18.03 | 18.74 | 16.1 | 5.68 |
Net Cash (Debt) Net Cash Growth | 89.37 | 85.1 | 136.45 | 149.55 | 211.25 | 249.36 |
Net Cash Growth | -25.18% | -37.63% | -8.76% | -29.21% | -15.29% | 789.36% |
Net Cash Per Share Net Cash Per Share Growth | 0.84 | 0.80 | 1.30 | 1.45 | 2.08 | 2.75 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -28.17 | -34.41 | -27.61 | -21.69 | -14.78 | -10.68 |
Capital Expenditures CapEx Growth | -1.19 | -1.77 | -1.65 | -3.7 | -18.48 | -3.83 |
Free Cash Flow Free Cash Flow Growth | -29.36 | -36.18 | -29.26 | -25.39 | -33.26 | -14.51 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 80.51% | 81.16% | 81.62% | 88.51% | 88.48% | 89.24% |
Operating Margin | -141.81% | -157.14% | -132.54% | -116.98% | -61.82% | -53.66% |
Pretax Margin | -121.16% | -135.14% | -106.29% | -91.85% | -53.25% | -56.30% |
Profit Margin | -121.16% | -135.14% | -106.29% | -91.85% | -53.25% | -56.30% |
FCF Margin | -90.92% | -109.54% | -75.75% | -61.49% | -75.15% | -42.82% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 3.68 | 5.01 | 11.38 | 11.83 | 12.63 | 30.43 |